Lin Li
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- Gut microbiota and health
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 17
- Circular RNAs in diseases 15
- Gut microbiota and health 14
-
- Cancer-related molecular mechanisms research 30
- MicroRNA in disease regulation 26
- Cancer Genomics and Diagnostics 15
- Co-authors
- Peide Huang (8 shared papers)Xuanlin Huang (6 shared papers)Guang Ning (3 shared papers)Yanan Cao (4 shared papers)Weiqing Wang (3 shared papers)Zhimin Feng (5 shared papers)Xiaohui Sun (4 shared papers)Fang Wen (1 shared paper)
- Journals
- Frontiers in Oncology (7 papers)Scientific Reports (5 papers)PLoS ONE (4 papers)European Journal of Pharmacology (4 papers)OncoTargets and Therapy (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin Li
238 papers receiving 6.7k citations
Lin Li's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.5k
- Molecular Biology 2.9k
- Biological Psychiatry 97
- Endocrinology 178
- Oncology 833
Countries citing papers authored by Lin Li
This map shows the geographic impact of Lin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Li more than expected).
Fields of papers citing papers by Lin Li
This network shows the impact of papers produced by Lin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Li. The network helps show where Lin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 248 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations Hit paper breakdown → | 2020 | 595 |
| 2 | γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO Hit paper breakdown → | 2014 | 432 |
| 3 | Genome-wide discovery and characterization of maize long non-coding RNAs Hit paper breakdown → | 2014 | 389 |
| 4 | Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients Hit paper breakdown → | 2021 | 215 |
| 5 | 2019 | 189 | |
| 6 | 2004 | 163 | |
| 7 | 2019 | 149 | |
| 8 | 2007 | 142 | |
| 9 | 2020 | 135 | |
| 10 | 2013 | 124 | |
| 11 | 2009 | 119 | |
| 12 | 2020 | 109 | |
| 13 | 2018 | 101 | |
| 14 | 2022 | 99 | |
| 15 | 2015 | 91 | |
| 16 | 2022 | 86 | |
| 17 | 2017 | 79 | |
| 18 | 2017 | 78 | |
| 19 | 2016 | 76 | |
| 20 | 2021 | 75 |
About Lin Li
Lin Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 248 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), MicroRNA in disease regulation (26 papers), RNA modifications and cancer (17 papers), Circular RNAs in diseases (15 papers), Cancer Genomics and Diagnostics (15 papers), Gut microbiota and health (14 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (2.9k citations), Biological Psychiatry (97 citations), Endocrinology (178 citations) and Oncology (833 citations). Lin Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Peide Huang, Xuanlin Huang, Guang Ning, Yanan Cao, Weiqing Wang, Zhimin Feng, Xiaohui Sun, Fang Wen, Shengqing Wan and Gong-Qing Shen. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, PLoS ONE, European Journal of Pharmacology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.